| Document Date: 2015-03-12 09:16:02
Open Document File Size: 24,66 KBShare Result on Facebook
City Brussels / New York / Paris / / Company Sanofi / Genzyme / / Country Belgium / France / United States / / Currency USD / EUR / / Event Company Listing Change / / IndustryTerm biopharmaceutical / body systems / therapeutic solutions / consumer healthcare / healthcare / diabetes solutions / / MedicalCondition just rheumatoid arthritis / arthritis / rheumatoid arthritis / severe diseases / Crohn’s disease / diabetes / immune-mediated disorders / joint diseases / ulcerative colitis / inflammatory bowel diseases / diseases / human diseases / immune-mediated diseases / / MedicalTreatment biologic therapies / / Person Elias Zerhouni / Ismail Kola / / Position President / President / Global R&D / global healthcare leader / / Technology therapeutic solutions / / URL www.ucb.com / /
SocialTag |
PRESS RELEASE Sanofi and UCB Partner for Breakthrough Innovation in Immune-mediated Diseases Paris, France, March 11, Sanofi (EURONEXT : SAN and NYSE : SNY) and UCB announce today they have entered into a scienti